Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RELEASE-HF study: a protocol for an observational, registry-based study on the effectiveness of telemedicine in heart failure in the Netherlands.
van Eijk J, Luijken K, Jaarsma T, Reitsma JB, Schuit E, Frederix GWJ, Derks L, Schaap J, Rutten FH, Brugts J, de Boer RA, Asselbergs FW, Trappenburg JCA; RELEASE-HF Investigators. van Eijk J, et al. Among authors: de boer ra. BMJ Open. 2024 Jan 4;14(1):e078021. doi: 10.1136/bmjopen-2023-078021. BMJ Open. 2024. PMID: 38176879 Free PMC article.
Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years.
van Essen BJ, Emmens JE, Tromp J, Ouwerkerk W, Smit MD, Geluk CA, Baumhove L, Suthahar N, Gansevoort RT, Bakker SJL, Damman K, van der Meer P, de Boer RA, van Veldhuisen DJ, Voors AA. van Essen BJ, et al. Among authors: de boer ra. Eur Heart J. 2024 Dec 30:ehae868. doi: 10.1093/eurheartj/ehae868. Online ahead of print. Eur Heart J. 2024. PMID: 39786471
Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
Schoonvelde SAC, Alexandridis GM, Price LB, Schinkel AFL, Hirsch A, Zwetsloot PP, Kammeraad JAE, van Slegtenhorst MA, Verhagen JMA, de Boer RA, Michels M. Schoonvelde SAC, et al. Among authors: de boer ra. Int J Cardiol. 2024 Dec 31;422:132951. doi: 10.1016/j.ijcard.2024.132951. Online ahead of print. Int J Cardiol. 2024. PMID: 39746469 Free article.
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers.
Hassanzada F, Jansen M, van Lint FHM, Bosman LP, Schmidt AF, Dooijes D, van de Sande D, Miah B, van der Crabben SN, Wilde AAM, Lekanne Deprez RH, de Boer RA, Christiaans I, Jongbloed JDH, Jorstad HT, Asselbergs FW, van Tintelen JP, Baas AF, Te Riele ASJM. Hassanzada F, et al. Among authors: de boer ra. Circ Genom Precis Med. 2024 Dec;17(6):e004561. doi: 10.1161/CIRCGEN.124.004561. Epub 2024 Dec 17. Circ Genom Precis Med. 2024. PMID: 39689185
Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors: Data From a Prospective Study.
van den Berg PF, Bracun V, Noordman M, van der Meer P, Shi C, Oosting SF, Aboumsallem JP, de Wit S, Meijers WC, Jalving M, van Kruchten M, de Boer RA. van den Berg PF, et al. Among authors: de boer ra. JACC Adv. 2024 Nov 7;3(12):101375. doi: 10.1016/j.jacadv.2024.101375. eCollection 2024 Dec. JACC Adv. 2024. PMID: 39583866 Free PMC article.
707 results